{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:28Z","timestamp":1762521388945,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10067-010-1550-z","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T09:32:01Z","timestamp":1282642321000},"page":"505-510","source":"Crossref","is-referenced-by-count":16,"title":["A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor \u03b1 inhibitor"],"prefix":"10.1007","volume":"30","author":[{"given":"Arjan J.","family":"Kwakernaak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieternella M.","family":"Houtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan F. L.","family":"Weel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna P. L.","family":"Spoorenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim L. T. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,25]]},"reference":[{"key":"1550_CR1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","volume":"370","author":"JS Smolen","year":"2007","unstructured":"Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P (2007) New therapies for treatment of rheumatoid arthritis. Lancet 370:1861\u20131874","journal-title":"Lancet"},{"key":"1550_CR2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/BOR.0b013e32832c7832","volume":"21","author":"PJ Mease","year":"2009","unstructured":"Mease PJ (2009) Psoriatic arthritis assessment and treatment update. Curr Opin Rheumatol 21:348\u2013355","journal-title":"Curr Opin Rheumatol"},{"key":"1550_CR3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.2005.040758","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316\u2013320","journal-title":"Ann Rheum Dis"},{"key":"1550_CR4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F et al (2003) Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 48:1093\u20131101","journal-title":"Arthritis Rheum"},{"issue":"Suppl 3","key":"1550_CR5","doi-asserted-by":"crossref","first-page":"iii55","DOI":"10.1136\/ard.60.90003.iii55","volume":"60","author":"HG Kraetsch","year":"2001","unstructured":"Kraetsch HG, Antoni C, Kalden JR, Manger B (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 60(Suppl 3):iii55\u2013iii57","journal-title":"Ann Rheum Dis"},{"key":"1550_CR6","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.rmed.2006.02.017","volume":"100","author":"S Saleh","year":"2006","unstructured":"Saleh S, Ghodsian S, Yakimova V, Henderson J, Sharma OP (2006) Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med 100:2053\u20132059","journal-title":"Respir Med"},{"key":"1550_CR7","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275\u20132285","journal-title":"JAMA"},{"key":"1550_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/BOR.0b013e3282fa74f7","volume":"20","author":"NM Patkar","year":"2008","unstructured":"Patkar NM, Teng GG, Curtis JR, Saag KG (2008) Association of infections and tuberculosis with antitumor necrosis factor alpha therapy. Curr Opin Rheumatol 20:320\u2013326","journal-title":"Curr Opin Rheumatol"},{"key":"1550_CR9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"1550_CR10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ Gomez-Reino","year":"2007","unstructured":"Gomez-Reino JJ, Carmona L, Angel Descalzo M (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57:756\u2013761","journal-title":"Arthritis Rheum"},{"key":"1550_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","author":"P Andersen","year":"2000","unstructured":"Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356:1099\u20131104","journal-title":"Lancet"},{"key":"1550_CR12","doi-asserted-by":"crossref","unstructured":"Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000; 161:1376\u20131395","DOI":"10.1164\/ajrccm.161.4.16141"},{"key":"1550_CR13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","volume":"59","author":"DY Chen","year":"2008","unstructured":"Chen DY, Shen GH, Hsieh TY, Hsieh CW, Lan JL (2008) Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy. Arthritis Rheum 59:800\u2013806","journal-title":"Arthritis Rheum"},{"key":"1550_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-126-3-199702010-00005","volume":"126","author":"J Pouchot","year":"1997","unstructured":"Pouchot J, Grasland A, Collet C, Coste J, Esdaile JM, Vinceneux P (1997) Reliability of tuberculin skin test measurement. Ann Intern Med 126:210\u2013214","journal-title":"Ann Intern Med"},{"key":"1550_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.200402-232OC","volume":"170","author":"I Brock","year":"2004","unstructured":"Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P (2004) Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 170:65\u201369","journal-title":"Am J Respir Crit Care Med"},{"key":"1550_CR16","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"YA Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI et al (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293:2756\u20132761","journal-title":"JAMA"},{"key":"1550_CR17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM Jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4:761\u2013776","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1550_CR18","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1378\/chest.06-2471","volume":"131","author":"A Lalvani","year":"2007","unstructured":"Lalvani A (2007) Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131(6):1898\u20131906","journal-title":"Chest"},{"key":"1550_CR19","unstructured":"Dutch Society of Rheumatology (2003) Tuberculosis and TNFa-blockade (guideline)"},{"key":"1550_CR20","first-page":"15","volume":"31","author":"GH Mazurek","year":"2003","unstructured":"Mazurek GH, Villarino ME (2003) Guidelines for using the QuantiFERON-TB test for diagnosing latent mycobacterium tuberculosis infection. Centers for disease control and prevention. MMWR Recomm Rep 31:15\u201318","journal-title":"MMWR Recomm Rep"},{"key":"1550_CR21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/CVI.00132-07","volume":"14","author":"EM Leyten","year":"2007","unstructured":"Leyten EM, Arend SM, Prins C, Cobelens FG, Ottenhoff TH, van Dissel JT (2007) Discrepancy between mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 14:880\u2013885","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"1550_CR22","first-page":"662","volume":"13","author":"S O\u2019Neal","year":"2009","unstructured":"O\u2019Neal S, Hedberg K, Markum A, Schafer S (2009) Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. Int J Tuberc Lung Dis 13(5):662\u2013664","journal-title":"Int J Tuberc Lung Dis"},{"key":"1550_CR23","first-page":"369","volume":"32","author":"A Saracino","year":"2009","unstructured":"Saracino A, Scotto G, Fornabaio C et al (2009) Quantiferon-TB Gold in-tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants in Italy. New Microbiol 32:369\u2013376","journal-title":"New Microbiol"},{"key":"1550_CR24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","volume":"30","author":"Y Kobashi","year":"2007","unstructured":"Kobashi Y, Obase Y, Fukuda M, Miyashita N, Oka M (2007) Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 30:945\u2013950","journal-title":"Eur Respir J"},{"key":"1550_CR25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1378\/chest.08-2575","volume":"136","author":"L Richeldi","year":"2010","unstructured":"Richeldi L, Losi M, D\u2019Amico R et al (2010) Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 136:198\u2013204","journal-title":"Chest"},{"key":"1550_CR26","first-page":"770","volume":"35","author":"JD Greenberg","year":"2008","unstructured":"Greenberg JD, Reddy SM, Schloss SG et al (2008) Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J Rheumatol 35:770\u2013775","journal-title":"J Rheumatol"},{"key":"1550_CR27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis G, Juni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67:84\u201390","journal-title":"Ann Rheum Dis"},{"key":"1550_CR28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3899\/jrheum.081292","volume":"36","author":"B Soborg","year":"2009","unstructured":"Soborg B, Ruhwald M, Hetland ML et al (2009) Comparison of screening procedures for mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol 36:1876\u20131884, 27","journal-title":"J Rheumatol"},{"key":"1550_CR29","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3899\/jrheum.090268","volume":"36","author":"N Inanc","year":"2009","unstructured":"Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H (2009) Agreement between Quantiferon-TB Gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 36:2675\u20132681","journal-title":"J Rheumatol"},{"key":"1550_CR30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","volume":"33","author":"F Bartalesi","year":"2009","unstructured":"Bartalesi F, Vicidomini S, Goletti D et al (2009) Quantiferon-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33:586\u2013593","journal-title":"Eur Respir J"},{"key":"1550_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12879-014-0741-7","volume":"15","author":"EY Kim","year":"2009","unstructured":"Kim EY, Jung JY, Son JY et al (2009) Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 15:9\u2013207","journal-title":"BMC Infect Dis"},{"key":"1550_CR32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.2008.101857","volume":"69","author":"J Martin","year":"2010","unstructured":"Martin J, Walsh C, Gibbs A et al (2010) Comparison of interferon-{gamma}-release assays and conventional screening tests before tumour necrosis factor-{alpha} blockade in patients with inflammatory arthritis. Ann Rheum Dis 69:181\u2013185","journal-title":"Ann Rheum Dis"},{"key":"1550_CR33","unstructured":"British National Institute for Health and Clinical Excellence (2006). Tuberculosis; clinical diagnosis and management of tuberculosis and measures for its prevention and control (guideline). London, UK:NICE:2006. http:\/\/www.nice.org.uk\/guidance\/CG33 . Accessed March 2009"},{"key":"1550_CR34","first-page":"620","volume":"137","author":"C Beglinger","year":"2007","unstructured":"Beglinger C, Dudler J, Mottet C et al (2007) Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly 137:620\u2013622","journal-title":"Swiss Med Wkly"},{"key":"1550_CR35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0029-1214673","volume":"63","author":"R Diel","year":"2009","unstructured":"Diel R, Hauer B, Loddenkemper R, Manger B, Kruger K (2009) Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases. Pneumologie 63:329\u2013334","journal-title":"Pneumologie"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10067-010-1550-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T23:53:38Z","timestamp":1740441218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1550-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["1550"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1550-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2010,8,25]]}}}